Dr M Rafiqul Islam

Consultant Clinical Oncologist

MBBS, MRCP (UK), FRCR


Specialises in

  • Clinical oncology
  • Cancer tests
  • Immunotherapy
  • Targeted therapy

Languages spoken

English, Bengali, Urdu, Hindi

I am a Consultant Clinical Oncologist who specialises in all non-surgical treatments for gastro-intestinal and lung cancers.

I treat lung and GI cancers using chemotherapy, biological therapy, immunotherapy, data from genome analysis and state of the art radiotherapy techniques including image guided radiotherapy (IGRT), MRL(ViewRay) and proton therapy. I am able to offer the combination of the above modalities and liaise with surgeons to offer a unique package for each patient. I specialise in stereotactic body radiotherapy (SBRT) for oligo-metastases and oligo-progressive disease in all types of cancer. I have been involved in lung and GI cancer trials as Principal and Co-investigator and have been published in many peer reviewed journals including The Green Journals. I have presented my work in national and international meetings.

I completed my specialist oncology training in many centres of excellence including Royal Marsden Hospital and Guy’s Hospital and obtained my Diploma in Oncology from Institute of Cancer Research (ICR), London. I was awarded the Brian Wither Travel Grant and Patricia McGregor Travel Fellowship to present my work in Florida, USA regarding precision Radiotherapy (SABR/SBRT). 

Alongside my work as a clinical oncologist, I am a core member of the expert group which authored the Radiotherapy for Lung Cancer for East of England and chair of the protocol writing committee for Rectal and Anal Cancer. I am also the guest Author for Breast Cancer Care.

Read more...

General Medical Council Number: C6137349

Treatment information

Some of the principal treatments carried out by Dr M Rafiqul Islam at Spire include:

Other treatments

  • Gastro-intestinal Cancer 
  • Immunotherapy
  • Lung Cancer 
  • Precision radiotherapy (SBRT/SABR)
  • Targeted therapy
  • Thymoma
  • Neuroendocrine

Get in touch

Important information about Covid-19 tests

COVID-19 testing or antibody tests are not available as a standalone service at Spire Wellesley Hospital.

105322
True
consultant

Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.


Submit my enquiry

Additional information

Bowel cancer
Chemotherapy
Gastrointestinal cancer
Lung cancer
Radiotherapy

Special clinical interests: Cancer of Unknown Primary (CUP).

FRCR / London / 2015
Fellow of the Royal College of Radiologists
FRCR is a degree given to Radiologists who specialise in oncology.


Professional memberships

Member of the General Medical Council (GMC)

Member of Royal College of Radiologists (RCR)

Member of the European Society of Medical Oncologists (ESMO)

Member of the European Society for Radiotherapy & Oncology (ESTRO)

Member of MDDUS (Professional Indemnity for Drs)

Royal College of Physicians (RCP)


Professional leadership

The Lung SABR co-lead at Southend University Hospital
Lead oncologist to treat colorectal and anal cancer at Mid Essex Hospital Trust (MEHT)


Articles

Dean J, Welsh L, Wong K, Aleksic A, Dunne E, Islam MR, Nutting C et.al. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clinical Oncology. 29 (2017) 263-273
Jan 2017

Sacco K, Muhammad A, Saleem W, Alshaker H, Monzon L, Islam MR, Pchejetski D. Leptomeningeal carcinomatosis as primary presentation of relapse in breast cancer (review). 2016 Aug;12(2):779-782.Oncology Letters.
16/06/2016

Dean J, Welsh L, Mcquaid D, Wong K, Aleksic A, Dunne E, Islam MR, Nutting C et.al. Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. Radiotherapy and Oncology.2016 Apr; 119(1): 166–171.Epub 2016 Feb 19.
19/02/2016

Kunene V, Miscoria M, Pirrie S, Islam MR, Afshar M, Porfiri E. Sarcomatoid Renal Cell Carcinoma: Clinical Outcome and Survival After Treatment with Sunitinib. Clinical Genitourinary Cancer. 2014 Aug;12(4): 251–5.
27/12/2013

Islam R, Lander F, Newbold K. Review of compliance with guidelines for risk stratification in low risk thyroid cancer at the Royal Marsden Hospital. Published as Abstract. Clinical ONCOLOGY.
29/06/2017

Consultant Oncologist at Southend University Hospital NHS Trust and Mid Essex Hospital, Broomfield.

I enjoy spending my spare time with my wife and three children and also enjoy gardening and travelling.

Telephone Spire Wellesley Hospital 01702 447 921
Private secretary Julie White and Ellie Grant
Private secretary telephone 07990 104 329